Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
3.19    0.24 (8.14%)
Bid:
3.00
Ask:
3.19
Spread: 0.19 (6.333%)
Market Cap: £5.82m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

AGM Statement

12 Jan 2018 07:00

RNS Number : 6646B
Nanoco Group PLC
12 January 2018
 

12 Jan 2018

NANOCO GROUP PLC

("Nanoco" or "the Company")

AGM Statement

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, will hold its Annual General Meeting ("AGM") later this morning at its headquarters in Manchester.

Dr Chris Richards, Nanoco's Chairman, will make the following statement:

"Since we updated the market in mid-November with our preliminary results we have continued to make good progress in the commercialisation of our CFQD® nanoparticle technology. This was underlined by a successful CES in Las Vegas this week, which was attended by industry players, customers and the financial community and generated several leads for both TVs and monitor products.

"We demonstrated a number of TVs and monitors equipped with Nanoco product at CES and we also launched the next generation of NANOCO CFQD® FINE COLOR FILM™. This new film delivers outstanding levels of brightness and colour performance, as the industry progresses on the roadmap to DCI-P3 and BT.2020 standards and away from cadmium-based solutions."

"We are encouraged by the increasing number of Nanoco equipped display products moving through to commercial production with customers in Asia. 

 "With the benefit of a strengthened balance sheet, the progress being made with our go-to-market strategy in Display and the emerging opportunities in other markets, we look forward to the year ahead with confidence."

 

For further information, please contact:

 

MHP Communications

Tel: +44 (0) 20 3128 8788

Reg Hoare / Andrew Leach / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nanotechnology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare and solar.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEAKFFFDXPEFF
Date   Source Headline
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSQuantum Dot Material Supply Agreement
30th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
30th Apr 20207:00 amRNSInterim Results
30th Apr 20207:00 amRNSTermination of Formal Sale Process
29th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
28th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
27th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
24th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
23rd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
22nd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
21st Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
20th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
17th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
16th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
15th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
14th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
9th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
8th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
7th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
6th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
3rd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
3rd Apr 202011:35 amRNSNanoco Group
2nd Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
31st Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
31st Mar 202011:07 amRNSNanoco Group
30th Mar 20201:05 pmRNSCovid-19 Update
30th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
27th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
26th Mar 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
25th Mar 20205:05 pmRNSLicence Partner Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.